LTA4 HYDROLASE INHIBITORS

The invention relates to compounds which constitute a class of medicaments which have an anti-inflammatory activity and which act by inhibiting leukotriene A4 (LTA4), and enzyme which is responsible for the biosynthesis of leukotriene LTB4, a major proinflammatory mediator. The invention also relate...

Full description

Saved in:
Bibliographic Details
Main Authors DANVY, DENIS, LECOMTE, JEANNE-MARIE, DUHAMEL, LUCETTE, MONTEIL, THIERRY, GROS, CLAUDE, PIETTRE, SERGE, SCHWARTZ, JEANARLES, PLAQUEVENT, JEANRISTOPHE, DUHAMEL, PIERRE, NOEL, NADINE, CHAMARD, OLIVIER
Format Patent
LanguageEnglish
French
German
Published 02.01.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to compounds which constitute a class of medicaments which have an anti-inflammatory activity and which act by inhibiting leukotriene A4 (LTA4), and enzyme which is responsible for the biosynthesis of leukotriene LTB4, a major proinflammatory mediator. The invention also relates to therapeutic anti-inflammatory, applications of these compounds as well as for methods of preparing these compounds.
AbstractList The invention relates to compounds which constitute a class of medicaments which have an anti-inflammatory activity and which act by inhibiting leukotriene A4 (LTA4), and enzyme which is responsible for the biosynthesis of leukotriene LTB4, a major proinflammatory mediator. The invention also relates to therapeutic anti-inflammatory, applications of these compounds as well as for methods of preparing these compounds.
Author SCHWARTZ, JEANARLES
LECOMTE, JEANNE-MARIE
DUHAMEL, LUCETTE
NOEL, NADINE
MONTEIL, THIERRY
PIETTRE, SERGE
CHAMARD, OLIVIER
DANVY, DENIS
PLAQUEVENT, JEANRISTOPHE
DUHAMEL, PIERRE
GROS, CLAUDE
Author_xml – fullname: DANVY, DENIS
– fullname: LECOMTE, JEANNE-MARIE
– fullname: DUHAMEL, LUCETTE
– fullname: MONTEIL, THIERRY
– fullname: GROS, CLAUDE
– fullname: PIETTRE, SERGE
– fullname: SCHWARTZ, JEANARLES
– fullname: PLAQUEVENT, JEANRISTOPHE
– fullname: DUHAMEL, PIERRE
– fullname: NOEL, NADINE
– fullname: CHAMARD, OLIVIER
BookMark eNrjYmDJy89L5WSQ9AlxNFHwiHQJ8vdxDHZV8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAYaGZqYmloaOhsZEKAEAoPwhVw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DE LTA4 HYDROLASE
LTA4 HYDROLASE INHIBITOREN
Edition 7
ExternalDocumentID EP1165491A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP1165491A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:21:38 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP1165491A13
Notes Application Number: EP20000917145
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020102&DB=EPODOC&CC=EP&NR=1165491A1
ParticipantIDs epo_espacenet_EP1165491A1
PublicationCentury 2000
PublicationDate 20020102
PublicationDateYYYYMMDD 2002-01-02
PublicationDate_xml – month: 01
  year: 2002
  text: 20020102
  day: 02
PublicationDecade 2000
PublicationYear 2002
RelatedCompanies BIOPROJET
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
RelatedCompanies_xml – name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
– name: BIOPROJET
Score 2.5389764
Snippet The invention relates to compounds which constitute a class of medicaments which have an anti-inflammatory activity and which act by inhibiting leukotriene A4...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title LTA4 HYDROLASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020102&DB=EPODOC&locale=&CC=EP&NR=1165491A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTJMTUpOMTDRTTUzTQEdqm2ia5lqDiwM01KTEy1SLA1TkkAbhX39zDxCTbwiTCOYGDJhe2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGqx3DJrbNVJzcbJ1DfB38XdWc3YGstT8gmxBp8yYWBo6AjtKrKBWNOiYfdcwJ9CmlALkGsVNkIEtAGhYXokQA1NakTADpzPs4jVhBg5f6Hw3kAnNesUiDJI-IY4mCh6RLkH-Po7Brgqefh6eTp4h_kHBogwKbq4hzh66QDvi4f6Jdw2Au8ZYjIEF2M1PlWBQMDFITjJJSUtOSwT2YNISLZIsUs0MjJMTzVNAXQ5zS0kGSZzGSOGRk2bgAt9gAho2MJJhYCkpKk2VBVakJUly4CAAACc8dN0
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjXik4PhRgS65XEghmdAeYWiqacGliXppTYtxr_vLinVi942u8nsI5mZ_WZ3vgF4UGRS4VpCIlGnNSPVRqJBNGoMG4JLvTbkumKJwnGiBq_oeT6dD2DZ58J0PKFfHTki1ShM9b3t7PX6J4jldn8rt4_VknZ9PPmF6Qo9OmZvu4rg2qaXpW7qCI5DW0KSm4xlBhmyRYHSgcbIednN6c1mSSnr3x7FP4HDjApbtacwaDZjGDl94bUxHMW7927a3Kne9gy4qLAQH7y7eRpZM48PkyC0wyLNZ-fA-17hBCKdY7Hfz8LL9quZXMCQwnxyCTyScIXqBjclRTBNqVc6UaUJLrWaQQ7N4ID7U8zVP2P3MAqKOFpEYfJyDcddNRMWQlBuYNhuPsktdaptddcdxzfGbXfK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=LTA4+HYDROLASE+INHIBITORS&rft.inventor=DANVY%2C+DENIS&rft.inventor=LECOMTE%2C+JEANNE-MARIE&rft.inventor=DUHAMEL%2C+LUCETTE&rft.inventor=MONTEIL%2C+THIERRY&rft.inventor=GROS%2C+CLAUDE&rft.inventor=PIETTRE%2C+SERGE&rft.inventor=SCHWARTZ%2C+JEANARLES&rft.inventor=PLAQUEVENT%2C+JEANRISTOPHE&rft.inventor=DUHAMEL%2C+PIERRE&rft.inventor=NOEL%2C+NADINE&rft.inventor=CHAMARD%2C+OLIVIER&rft.date=2002-01-02&rft.externalDBID=A1&rft.externalDocID=EP1165491A1